Bruker Corporation (BRKR)

業務介紹

布魯克公司在美國和國際上開發、製造和分銷科學儀器、分析和診斷解決方案。該公司通過三個部門運營:布魯克科學儀器(BSI)生命科學、BSI納米和布魯克能源和超導技術。它提供生命科學工具、單一和多模態系統;生命科學質譜儀;MALDI Biotyper快速病原體識別平台和相關試劑盒、DNA試驗條和基於熒光的聚合酶鏈反應技術;基因型和熒光型分子診斷試劑盒;研究、分析和過程分析儀器和解決方案;用於診斷COVID-19感染的SARS-CoV 2檢測;以及Fluorotyper-SARS-CoV 2 plus試劑盒。它還提供一系列便攜式分析和生物分析檢測系統及相關產品;X射線儀器;電子顯微鏡分析工具,以及手持、便攜和移動X射線熒光光譜儀儀器;原子力顯微鏡儀器;非接觸納米米級解決方案拓撲圖;以及自動化X射線測量、自動化AFM缺陷檢測和光罩修復和清潔設備。此外,該公司還提供先進的光學熒光顯微鏡儀器;支持轉化研究、藥物和生物標誌物發現的研究人員多組學需求的產品和服務;金屬低溫超導體;基於金屬低溫超導體的設備和複雜工具;以及非超導高科技工具,如同步輻射和光束線儀器。布魯克公司與Newomics Inc.合作開發一種用於藥物發現的LC-MS平台。該公司成立於1991年,總部位於馬薩諸塞州比爾里卡。



Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

公司網址

https://www.bruker.com